Cargando…
BRAF(V600E) immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells: A STROBE-Compliant article
Treatment of BRAF(V600E)-mutant melanoma by small molecule inhibitors that target BRAF or MEK kinases is increasingly used in clinical practice and significantly improve patient outcome. However, patients eventually become resistant and therapeutic improvement is required. Molecular diversity within...
Autores principales: | Verlinden, Ivana, van den Hurk, Karin, Clarijs, Ruud, Willig, Arjan P., Stallinga, Cecile M.H.A., Roemen, Guido M.J.M., van den Oord, Joost J., zur Hausen, Axel, Speel, Ernst-Jan M., Winnepenninckx, Véronique J.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603111/ https://www.ncbi.nlm.nih.gov/pubmed/25526463 http://dx.doi.org/10.1097/MD.0000000000000285 |
Ejemplares similares
-
BRAF(V600E) Immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells: A STROBE-Compliant Article: Erratum
Publicado: (2015) -
Trends and projections in cutaneous melanoma death in the Netherlands from 1950 to 2045
por: van Niekerk, Catharina C., et al.
Publicado: (2021) -
Quantitative Analysis of Immunohistochemistry in Melanoma Tumors
por: Lilyquist, Jenna, et al.
Publicado: (2017) -
Delay in cutaneous melanoma diagnosis: Sequence analyses from suspicion to diagnosis in 211 patients
por: Xavier, Marcus H.S.B., et al.
Publicado: (2016) -
Allele frequency and the associations of HLA-DRB1 and HLA-DQB1 polymorphisms with pemphigus subtypes and disease severity
por: Le, Thanh Thai Van, et al.
Publicado: (2022)